Prashant Hiwarkar

Bone Marrow Transplant physician and Paediatric haematologist

[Prashant Hiwarkar @p_hiwarkar]

@indiacares_2020 @wadiahospitals Thank you so much for your kind words! It was an honor to be part of Aryan's journey, and we're thrilled to see him doing well. This success reflects the collective effort and dedication of our entire team. Wishing Aryan continued strength and health!

[Prashant Hiwarkar @p_hiwarkar]

A novel disease-burden-adapted protocol combining Inotuzumab and Blinatumomab shows 95% MRD-negative remission in high-risk relapsed pediatric B-ALL. A promising, low-toxicity bridge to transplant. #Leukemia #Pediatrics #Immunotherapy

https://t.co/zuJex3IU1a

[Prashant Hiwarkar @p_hiwarkar]

@pho_india @TheEBMT @THEEBMT_Trainee @TheEBMT_CTIWP @ASTCT @SciReports @IsbmtU @drambreenp @Parulbrat

[Prashant Hiwarkar @p_hiwarkar]

Can we achieve the “Goldilocks zone” for post-transplant immune-reconstitution?

A small step toward enhancing immune-reconstitution using the often-overlooked dimension of graft T cells.

[Prashant Hiwarkar @p_hiwarkar]

The next phase involves refining the grafting technique by incorporating the parameter of pre-graft alemtuzumab levels, aiming for predictable immune reconstitution (shown in the PowerPoint slide). #BoneMarrowTransplant #ImmuneReconstitution #StemCellTransplant #MedTwitter

[amby @drambreenp]

Our first outcome data in #PID transplants with an overall survival of 95% and immunodeficiency free survival of 86%! Achieving comparable results to the developed countries @p_hiwarkar @WorldPIWeek @Info4PI @ipopi_info #DataforPIDs #WorldPIWeek

https://t.co/bhIv3wSYEV

[amby @drambreenp]

Happy diwali! @p_hiwarkar

[Prashant Hiwarkar @p_hiwarkar]

@drambreenp @Saneya_2810 Congratulations to both. Well done!!

[Prashant Hiwarkar @p_hiwarkar]

@drambreenp @drkunalsehgal Rapid diagnosis of Immunodeficiency symbolises a patient centric approach - New Beginnings of approach to primary immunodeficiencies in India